Compare ITT & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITT | FMS |
|---|---|---|
| Founded | 1920 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 14.1B |
| IPO Year | N/A | 1996 |
| Metric | ITT | FMS |
|---|---|---|
| Price | $181.17 | $23.27 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 10 | 2 |
| Target Price | ★ $201.11 | $30.00 |
| AVG Volume (30 Days) | ★ 592.3K | 482.1K |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | 0.78% | ★ 2.45% |
| EPS Growth | 2.16 | ★ 8.62 |
| EPS | ★ 5.99 | 2.86 |
| Revenue | $3,813,500,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $7.91 | $2.12 |
| Revenue Next Year | $5.90 | $2.92 |
| P/E Ratio | $30.21 | ★ $15.86 |
| Revenue Growth | ★ 8.01 | 2.10 |
| 52 Week Low | $105.64 | $22.05 |
| 52 Week High | $197.07 | $30.46 |
| Indicator | ITT | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 47.61 | 37.10 |
| Support Level | $177.48 | $22.51 |
| Resistance Level | $183.44 | $24.20 |
| Average True Range (ATR) | 5.03 | 0.30 |
| MACD | -0.46 | 0.09 |
| Stochastic Oscillator | 53.79 | 45.27 |
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.